Browsing: pharma

This is a paid press release. Contact the press release distributor directly with any inquiries.

According to the latest IndexBox report on the global Tamper-Evident Seals market, the market enters 2026 with broader demand fundamentals, more disciplined procurement behavior, and a more regionally diversified supply architecture.

Moderna shares dropped as much as 25% following the leak of partial data on its closely watched cancer vaccine developed with Merck.The stock fell even though the full data, released later Thursday following the leak, appeared positive relative to Wall Street expectations. (CNBC)

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Germany’s bid to revive its struggling economy faces a fresh setback as a major pharmaceutical player raises concerns over the country’s business climate.

Pfizer Inc. (NYSE:PFE) trades at a considerable discount to AbbVie Inc. (NYSE:ABBV), despite both companies reporting growth in important parts of their pharmaceutical portfolios. According to Yahoo Finance’s September 23, 2026 valuation snapshot, Pfizer trades at 9.67 times forward earnings, compared with AbbVie’s 16.39 times.

Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Premier Strategy” third-quarter 2026 investor letter. The letter can be downloaded here. In Q3 2026, strengthening macroeconomic headwinds—rising interest rates, inflation, and elevated energy prices—weighed on equities, though AI enthusiasm buoyed index leaders. Mar Vista’s U.S. Quality Premier strategy returned…

Eli Lilly is taking its direct-to-consumer playbook to Australia. The drugmaker is bypassing traditional pharmacy channels with a new model there, another sign that pharma companies are experimenting with more direct relationships with patients as competition in obesity medicines intensifies. (STAT News)

Yuyu Pharma (000220.KS) CEO Yoo Won-sang attended Amazon’s annual seller conference to explore ways to expand the company’s cat health products now sold in the United States. The plan is to feed feedback from local consumers into product development and brand management.